Figures computed from official regulatory filings — .
Analysttarget 4.14 USD (+594%) · consensus 4.17/5 · 5 buy · 1 hold · 0 sell
Ownershipinsiders 2.05% · institutions 3.3% · short 6.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ONCOLYTICS BIOTECH INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal ("GI") tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
14 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Glover Steve Ctrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) |
| Kelly Jared | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Seizinger Bernd R.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Brown Deborah Margaret | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Holtham Angela | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Andrews Patricia S | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hagerman Allison | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Look Kirk | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Heineman Thomas Charles | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RIGBY JONATHAN | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Aromando Andrew | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| McAdory John Bearden | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pisano Waynetrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Parsons James T. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Parsons James T. | Buy | $10.3K | conv 59ClusterFirst in 12mo | SEC |
| Kelly Jared | Buy | $4.8K | conv 59Cluster | SEC |
| Seizinger Bernd R.track record | Buy | $49.8K | conv 46Cluster | SEC |
| Pisano Waynetrack record | Buy | $25.2K | conv 59ClusterUnusual size | SEC |
| Kelly Jared | Buy | $24.8K | conv 70Cluster | SEC |
| Seizinger Bernd R.track record | Buy | $34K | conv 43Cluster | SEC |
| Hagerman Allison | Buy | $8.3K | conv 64ClusterFirst in 12mo | SEC |
| Brown Deborah Margaret | Buy | $21.3K | conv 66ClusterFirst in 12mo | SEC |
| Kelly Jared | Buy | $4.7K | conv 67ClusterFirst in 12mo | SEC |
| Aromando Andrew | Buy | $25.5K | conv 92ClusterFirst in 12mo | SEC |
| Look Kirk | Buy | $10.1K | conv 68ClusterFirst in 12mo | SEC |